Atrial Natriuretic Factor in the Landry–Guillain–Barré Syndrome
- 18 August 1988
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 319 (7) , 448
- https://doi.org/10.1056/nejm198808183190714
Abstract
To the Editor: Atrial natriuretic factor (ANF) may have a physiologic role in cardiocirculatory homeostasis. In humans, synthetic α-ANF decreases blood pressure, produces an extravascular shift of fluid, and promotes diuresis and natriuresis.1 Endogenous plasma ANF increases in response to hypervolemia,2 which is thought to activate ANF release through atrial distention.3 The plasma ANF level has also been noted to rise during acute hypertension induced by the infusion of vasopressor hormones.4 However, whether spontaneous fluctuations in systemic blood pressure are accompanied by changes in ANF release has been unknown.Instability of blood pressure is a characteristic consequence of baroreflex dysfunction. . . .Keywords
This publication has 5 references indexed in Scilit:
- Atrial Natriuretic Peptide in ManAmerican Journal of Nephrology, 1988
- Effects of Posture and Ageing on Circulating Atrial Natriuretic Peptide Levels in ManJournal Of Hypertension, 1987
- Pressure dependence of atrial natriuretic peptide during norepinephrine infusion in humans.Hypertension, 1987
- Blood levels and renal effects of atrial natriuretic peptide in normal man.Journal of Clinical Investigation, 1986
- Autonomic dysfunction in the Guillain-Barré syndrome. Hemodynamic and neurobiochemical studiesIntensive Care Medicine, 1980